Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Maria Patra"'
Autor:
Alexander Biedermann, Maria Patra-Kneuer, Dimitrios Mougiakakos, Maike Büttner-Herold, Doris Mangelberger-Eberl, Johannes Berges, Christian Kellner, Sarah Altmeyer, Jörg Thomas Bittenbring, Christian Augsberger, Kristina Ilieva-Babinsky, Stefan Haskamp, Fabian Beier, Christopher Lischer, Julio Vera, Anja Lührmann, Simone Bertz, Simon Völkl, Benedikt Jacobs, Stefan Steidl, Andreas Mackensen, Heiko Bruns
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Macrophages are one of the key mediators of the therapeutic effects exerted by monoclonal antibodies, such as the anti-CD19 antibody tafasitamab, approved in combination with lenalidomide for the treatment of relapsed or refractory (r/r) diffuse larg
Externí odkaz:
https://doaj.org/article/83e0d53a47ba41ce83058f40a666be1f
Autor:
Kristina Ilieva, Markus Eberl, Jan Jaehrling, Derek Blair, Maria Patra-Kneuer, Rainer Boxhammer, Diana Alvarez Arias, Christina Heitmüller
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionSeveral CD19 targeted antibody-based therapeutics are currently available for patients with diffuse large B-cell lymphoma (DLBCL), including the Fc-modified antibody immunotherapy tafasitamab. This therapeutic landscape warrants the evalu
Externí odkaz:
https://doaj.org/article/60dffec1b62f45f4b2339a4dfc29384e
Autor:
Arshi Arora, Maria Patra-Kneuer, Gaomei Chang, Christian Kuffer, Michael Grau, Myroslav Zapukhlyak, Derek Blair, Kristina Ilieva, Christina Heitmueller, Georg Lenz, Michael Schaffer, Diana Alvarez Arias
Publikováno v:
HemaSphere, Vol 7, p e69573fd (2023)
Externí odkaz:
https://doaj.org/article/5b7a11de9b4848fbbceabc8b3ef25f02
Autor:
Maria Patra-Kneuer, Gaomei Chang, Wendan Xu, Christian Augsberger, Michael Grau, Myroslav Zapukhlyak, Kristina Ilieva, Karin Landgraf, Doris Mangelberger-Eberl, Kasra Yousefi, Philipp Berning, Katrin S. Kurz, German Ott, Pavel Klener, Cyrus Khandanpour, Pedro Horna, Jürgen Schanzer, Stefan Steidl, Jan Endell, Christina Heitmüller, Georg Lenz
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundDespite recent advances in the treatment of aggressive lymphomas, a significant fraction of patients still succumbs to their disease. Thus, novel therapies are urgently needed. As the anti-CD20 antibody rituximab and the CD19-targeting anti
Externí odkaz:
https://doaj.org/article/df1ed81873764c6288a33fb66d4e0cae
Autor:
Reona Leo Sakemura, Claudia Manriquez-Roman, Paulina Horvei, Michelle J. Cox, Truc Huynh, James H. Girsch, Olivia Sirpilla, Kun Yun, Carli M. Stewart, Ismail Can, Ekene J. Ogbodo, Mohamad M. Adada, Lionel A. Kankeu Fonkoua, Mehrdad Hefazi, Michael W. Ruff, Kristina Ilieva-Babinsky, Christian Augsberger, Maria Patra-Kneuer, Christina Heitmüller, Stefan Steidl, Sameer A. Parikh, Wei Ding, Neil E. Kay, Grzegorz S. Nowakowski, Elizabeth L. Siegler, Saad S. Kenderian
Publikováno v:
Blood. 140:2362-2364
Autor:
Jung Hyun Her, Dominik Pretscher, Maria Patra-Kneuer, Juergen Schanzer, Sung Yoo Cho, Yu Kyeong Hwang, Timm Hoeres, Rainer Boxhammer, Christina Heitmueller, Martin Wilhelm, Stefan Steidl, Jan Endell
Publikováno v:
Cancer Immunology, Immunotherapy. 71:2829-2836
Tafasitamab is an Fc-modified monoclonal antibody that binds to CD19, a cell-surface antigen that is broadly expressed on various types of B-cell non-Hodgkin’s lymphoma (NHL). Antibody-dependent cellular cytotoxicity (ADCC), a key mode of action of
Autor:
R. Leo Sakemura, Claudia Manriquez Roman, Paulina Horvei, Truc N Huynh, James H. Girsch, Olivia Sirpilla, Kun Yun, Carli M. Stewart, Ismail Can, Ekene J. Ogbodo, Mohamad M. Adada, Lionel Aurelien Kankeu Fonkoua, Mehrdad Hefazi, Michael W. Ruff, Kristina Ilieva-Babinsky, Christian Augsberger, Maria Patra-Kneuer, Christina Heitmüller, Stefan Steidl, Sameer A. Parikh, Wei Ding, Neil E. Kay, Grzegorz S Nowakowski, Elizabeth L. Siegler, Saad S. Kenderian
Publikováno v:
Transplantation and Cellular Therapy. 29:S11-S12
Autor:
Alexander Biedermann, Doris Mangelberger-Eberl, Dimitrios Mougiakakos, Maike Büttner-Herold, Cindy Flamann, Christian Kellner, Sarah Altmeyer, Jörg Bittenbring, Christian Augsberger, Maria Patra-Kneuer, Karin Landgraf, Kristina Ilieva-Babinsky, Stefan Haskamp, Fabian Beier, Simon Voelkl, Christian Pallasch, Benedikt Jacobs, Stefan Steidl, Christina Heitmüller, Andreas Mackensen, Heiko Bruns
Publikováno v:
Blood. 140:9292-9293
Autor:
Evandro D. Bezerra, Ekene J. Ogbodo, Wei Ding, Jan Endell, Michael W. Ruff, Christian Augsberger, Elizabeth L. Siegler, Erin E. Tapper, Juergen Schanzer, Christina Heitmüller, Grzegorz S. Nowakowski, Stefan Steidl, Lionel A. Kankeu Fonkoua, Michelle J. Cox, Paulina Horvei, Mehrdad Hefazi, Reona Sakemura, Mohamad M. Adada, Saad S. Kenderian, Susan L. Slager, Ismail Can, Kendall J. Schick, Carli M. Stewart, Sameer A. Parikh, Neil E. Kay, Claudia Manriquez-Roman, Maria Patra-Kneuer
Publikováno v:
Transplantation and Cellular Therapy. 28:S163-S164
With the development of various strategies of anti-CD19 immunotherapy for treatment of B cell malignancies, it remains to be elucidated whether CD19 targeting with a monoclonal antibody impairs subsequent CD19 targeted chimeric antigen receptor T cel
Autor:
Maria Patra-Kneuer, Stefan Steidl, Akito Nakamura, Andrea Polzer, Stephen Grossman, Igor Proscurshim, Carmen Ginzel, Keli Song, Christina Heitmüller, Allison Berger
Publikováno v:
Blood. 138:2268-2268
Introduction TAK-981 is a first-in-class small molecule inhibitor of the SUMO activating enzyme currently in Phase I/II clinical trials. TAK-981 has been shown to increase NK cell activation and M1 macrophage polarization via upregulation of Type I i